Get the app!
Back to Trades
Grant4

Moderna, Inc.

MRNA

Total Value
$53.7K

Company Information

Company Name
Moderna, Inc.
Ticker Symbol
MRNA
CIK
0001682852

Insider Information

Role
Chief Financial Officer
Officer
Location
CAMBRIDGE, MA

Filing Details

Filing Date
Feb 13, 2026
Transaction Date
Feb 11, 2026
Accession Number
0001682852-26-000024
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Feb 11, 2026Common Stock2,630Grant/Award
Feb 11, 2026Common Stock1,278$41.99Tax Withholding$53.7K

Footnotes

  1. (F1)The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on February 28, 2023 (the "2023 PSUs").
  2. (F2)Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2023 PSUs.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.